Inotiv Inc reports results for the quarter ended in December - Earnings Summary

Inotiv

07/02/2024 22:46

* Inotiv Inc  NOTV.OQ  reported a quarterly adjusted loss
of 60
cents​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of
$-3.41.  The mean expectation of three analysts for the quarter
was for a loss of 85 cents per share. Wall Street expected
results to range from -88 cents to -83 cents per share.
    * Revenue rose 10.4% to $135.50 million from a year ago;
analysts
expected $132.86 million. 
    * Inotiv Inc's reported EPS for the quarter was a loss of 60
cents​.
    * The company reported a quarterly loss of $15.39 million.
    * Inotiv Inc shares had risen by 1.9% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 42.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Inotiv Inc is
$14.00 
This summary was machine generated from LSEG data February 7 at
10:45 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.85          -0.60          Beat
 Sep. 30 2023      -0.33          -0.38          Missed
 Jun. 30 2023      -0.10          0.07           Beat
 Mar. 31 2023      -0.42          -0.39          Beat